» Articles » PMID: 15659372

Crystal Structure of the Complex Formed Between a Group I Phospholipase A2 and a Naturally Occurring Fatty Acid at 2.7 A Resolution

Overview
Journal Protein Sci
Specialty Biochemistry
Date 2005 Jan 22
PMID 15659372
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

This is the first evidence of a naturally bound fatty acid to a group I Phospholipase A(2) (PLA(2)) and also to a PLA(2) with Asp 49. The fatty acid identified as n-tridecanoic acid is observed at the substrate recognition site of PLA(2) hydrophobic channel. The complex was isolated from the venom of Bungarus caeruleus (Common Indian Krait). The primary sequence of the PLA(2) was determined using the cDNA method. Three-dimensional structure has been solved by the molecular replacement method and refined using the CNS package to a final R factor of 19.8% for the data in the resolution range from 20.0 to 2.7 A. The final refined model is comprised of 912 protein atoms, one sodium ion, one molecule of n-tridecanoic acid, and 60 water molecules. The sodium ion is located in the calcium-binding loop with a sevenfold coordination. A characteristic extra electron density was observed in the hydrophobic channel of the enzyme, into which a molecule of n-tridecanoic acid was clearly fitted. The MALDI-TOF measurements of the crystals had earlier indicated an increase in the molecular mass of PLA(2) by 212 Da over the native PLA(2). A major part of the ligand fits well in the binding pocket and interacts directly with His 48 and Asp 49. Although the overall structure of PLA(2) in the present complex is similar to the native structure reported earlier, it differs significantly in the folding of its calcium-binding loop.

Citing Articles

Convergent evolution of pain-inducing defensive venom components in spitting cobras.

Kazandjian T, Petras D, Robinson S, van Thiel J, Greene H, Arbuckle K Science. 2021; 371(6527):386-390.

PMID: 33479150 PMC: 7610493. DOI: 10.1126/science.abb9303.


Viperatoxin-II: A novel viper venom protein as an effective bactericidal agent.

Perumal Samy R, Stiles B, Chinnathambi A, Zayed M, Alharbi S, Franco O FEBS Open Bio. 2016; 5:928-41.

PMID: 26793432 PMC: 4688439. DOI: 10.1016/j.fob.2015.10.004.


The mode of inhibitor binding to peptidyl-tRNA hydrolase: binding studies and structure determination of unbound and bound peptidyl-tRNA hydrolase from Acinetobacter baumannii.

Kaushik S, Singh N, Yamini S, Singh A, Sinha M, Arora A PLoS One. 2013; 8(7):e67547.

PMID: 23844024 PMC: 3701073. DOI: 10.1371/journal.pone.0067547.


Scorpion peptides: potential use for new drug development.

Hmed B, Serria H, Mounir Z J Toxicol. 2013; 2013:958797.

PMID: 23843786 PMC: 3697785. DOI: 10.1155/2013/958797.

References
1.
de Azevedo Jr W, Ward R, Gutierrez J, Arni R . Structure of a Lys49-phospholipase A2 homologue isolated from the venom of Bothrops nummifer (jumping viper). Toxicon. 1999; 37(2):371-84. DOI: 10.1016/s0041-0101(98)00189-5. View

2.
Lee W, da Silva Giotto M, Marangoni S, Toyama M, Polikarpov I, Garratt R . Structural basis for low catalytic activity in Lys49 phospholipases A2--a hypothesis: the crystal structure of piratoxin II complexed to fatty acid. Biochemistry. 2001; 40(1):28-36. DOI: 10.1021/bi0010470. View

3.
Singh G, Gourinath S, Sharma S, Paramasivam M, Srinivasan A, Singh T . Sequence and crystal structure determination of a basic phospholipase A2 from common krait (Bungarus caeruleus) at 2.4 A resolution: identification and characterization of its pharmacological sites. J Mol Biol. 2001; 307(4):1049-59. DOI: 10.1006/jmbi.2001.4550. View

4.
Chandra V, Jasti J, Kaur P, Betzel C, Srinivasan A, Singh T . First structural evidence of a specific inhibition of phospholipase A2 by alpha-tocopherol (vitamin E) and its implications in inflammation: crystal structure of the complex formed between phospholipase A2 and alpha-tocopherol at 1.8 A resolution. J Mol Biol. 2002; 320(2):215-22. DOI: 10.1016/S0022-2836(02)00473-4. View

5.
Chandra V, Jasti J, Kaur P, Dey S, Perbandt M, Srinivasan A . Crystal structure of a complex formed between a snake venom phospholipase A(2) and a potent peptide inhibitor Phe-Leu-Ser-Tyr-Lys at 1.8 A resolution. J Biol Chem. 2002; 277(43):41079-85. DOI: 10.1074/jbc.M206130200. View